Icon
+91 94997 68112
Login Register

Sancuso - ( 3.1 mg/24 hr; Film, Extended Release, Transdermal)

Granisetron Hydrochloride Kyowa
3.1 mg/24 hr; Film, Extended Release, Transdermal
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.
Yes
**** ** *** ***** ** **** **** ** **** ****** '*** (*** **, ****) *** *** ************ *********. ***** ***** **** ****** '*** (*** **, ****) ** ***** *** ********* ** ****, ***** **** ****** ****** *** ******* **** *** **, ****. ******* ******* ******** ******** *****'* ******** **** '*** (*** **, ****) ****** ** ******** ** ****.
Sancuso Patent 1
**** **** ** **
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** **** **, **** **** ** ** **** ***** *** ****
  1. *** *, **** : **** (*******) ******** ***** (**********) ***** *** **** ** **** ****** '*** (*** **, ****).
  2. *** **, **** : ***** (**********) ***** * **** ******* **** ** ******** ***** ** ******* ******** ** ***** ******** ********.
  3. *** **, **** : ***** ***** **** **** ********* ****** '*** (*** **, ****) *** **** *** ****** ** *****.
  4. *** **, **** : ******* ******* ******** ******** *****'* ******** **** '*** (*** **, ****) ****** ** ******** ** ****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.